CoreWeave Faces Securities Class Action in New Jersey Federal Court

The case centers on claims that the AI infrastructure company overstated its capacity and concealed supplier-driven construction delays that hurt results.

Overview

The lawsuit, captioned Masaitis v. CoreWeave, Inc., No. 2:26-cv-00355, is pending in the U.S. District Court for the District of New Jersey.
Investors who bought CoreWeave securities between March 28, 2025 and December 15, 2025 comprise the putative class, with a March 13, 2026 deadline to seek lead-plaintiff status.
Complaints allege executives overstated the ability to meet demand and understated risks tied to reliance on a single third‑party data‑center supplier, affecting revenue recognition tied to completed sites.
Key disclosures include the Oct. 30, 2025 termination of the Core Scientific merger, Nov. 10 guidance cuts citing third‑party delays, a Nov. 11 CNBC exchange where CEO Michael Intrator acknowledged a single provider was involved, and a Dec. 15 Wall Street Journal report on Denton, Texas delays.
Following these events, shares fell about 34% from Nov. 10 to Dec. 16, 2025, erasing roughly $14 billion in market value, and multiple law firms are now soliciting investors as the litigation remains at an early stage without class certification.